BioSpace News Archive

IO Biotech announced that the Company will be participating in the Jefferies Global Healthcare Conference, to be held June 8-10, 2022, in New York City.

CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and other chronic diseases, today announced that results from new analyses of clinical studies of seladelpar were presented during Digestive Disease Week® (DDW) .

Compass Therapeutics, Inc. announced Thomas J. Schuetz, M.D., Ph.D., Co-founder and Chief Executive Officer, is presenting virtually at the 2022 H.C. Wainwright Global Investment Conference, occurring May 23-26th, 2022.

RAPT Therapeutics, Inc. (Nasdaq: RAPT), today announced it has initiated its 16-week randomized, double-blind, placebo-controlled Phase 2b clinical trial to further evaluate the efficacy and safety of RPT193 as monotherapy in patients with moderate-to-severe atopic dermatitis (AD).

Recce Pharmaceuticals Ltd. (ASX:RCE, FSE:R9Q) (the Company), the company developing a new class of synthetic anti-infectives, today announced that in cohort five of a Phase I clinical trial, R327 demonstrated a good safety and tolerability profile among 10 healthy male subjects intravenously dosed at 2,000mg.

Ascendis Pharma A/S (Nasdaq: ASND) announced today that results from VISEN Pharmaceuticals’ Phase 3 trial of once-weekly TransCon hGH in children with GHD in China demonstrated results that were consistent with the Ascendis Pharma’s earlier multi-national Phase 3 trial.

Ascendis Pharma A/S (Nasdaq: ASND) today announced new Endocrinology commercial leadership appointments following the retirement of Global Chief Commercial Officer Jesper Høiland.

Enlivex Therapeutics Ltd., a clinical-stage macrophage reprogramming immunotherapy company, announced the appointment of Roger J. Pomerantz, M.D., FACP, to its Board of Directors as Vice Chairman.

Rockwell Medical, Inc. announced that Russell Ellison, M.D., M.Sc., President and Chief Executive Officer is scheduled to present at H.C. Wainwright’s Annual Global Life Sciences Conference in Miami, Florida on Tuesday, May 24th at 3:30 PM ET.

OncoSec Medical Incorporated announced that it is the recipient of the 2022 Vanguard Award presented by the Triple Negative Breast Cancer Foundation.